1 inders for 1 year; and (5) a case discussion
seminar.
2 vement in short-term knowledge after the ACR
seminar.
3 sts to assess knowledge before and after the
seminar.
4 ad training in breast imaging before the ACR
seminar.
5 e of atopic dermatitis are discussed in this
Seminar.
6 is is a large topic beyond the scope of this
Seminar.
7 Hodgkin lymphoma, which is the topic of this
Seminar.
8 vitiligo will be emphasised throughout this
Seminar.
9 was interest in an ongoing series of virtual
seminars.
10 ut MAP through introductions and role plays (
seminar 1), followed by actively planning and conducting
11 atients in a case seminar under supervision (
seminar 2).
12 tandard information plus: (1) an educational
seminar; (
2) educational materials; (3) a list of availa
13 l courses but was heavily involved in making
seminars a vital part of instruction, in teaching langua
14 This Seminar adds to the previous Lancet
Seminar about eating disorders, published in 2003, with
15 This
seminar addresses only the musculoskeletal issues associ
16 This
Seminar adds to the previous Lancet Seminar about eating
17 This
Seminar aims to provide a comprehensive overview of the
18 This
Seminar aims to provide a thorough overview of these uni
19 This
Seminar aims to provide insights into the current clinic
20 This
Seminar also summarises management considerations accord
21 titioners, and nurses) included an in-person
seminar,
an online course, management algorithms (poster
22 We developed a course that combines
seminar and independent research elements to support stu
23 -specific knowledge prior to the educational
seminar and should be recommended to every affected pers
24 the pros and cons of virtual conferences and
seminars and how these could change the nature of scient
25 nd the literature and through osmosis during
seminars and scientific meetings.
26 rectify this issue through short workshops,
seminars,
and conferences.
27 lude use of joint grand rounds, patient care
seminars,
and interprofessional dialogues.
28 pate and to be interviewed after information
seminars at the different centers.
29 ne; and Matthew (MK) has been organizing Eco
Seminars at the University of California, San Francisco
30 n an exploratory process with a 2-day hybrid
seminar centred on three promising innovative strategies
31 ducational intervention consisted of a 1-day
seminar co-taught by a Tanzanian pastor and a Tanzanian
32 An outreach educational
seminar combined with implementation of on-site sigmoido
33 ling" in the form of an outreach educational
seminar combined with implementation of on-site sigmoido
34 This
Seminar covers the basics, from terminology to aspects o
35 This
Seminar covers the recent reclassification of steatotic
36 This
Seminar describes embryological developmental processes,
37 This
Seminar describes the clinical manifestations of androge
38 This
Seminar describes the epidemiology, lifecycles, pathophy
39 the waiting list control group prior to the
seminar did not show a nonspecific increase in disease k
40 In this
Seminar,
different causes of HUS are discussed, the most
41 This
Seminar discusses current progress in epidemiology, path
42 This focus
seminar discusses recent trends in donor and recipient p
43 This second part of a 4-part JACC Focus
Seminar discusses the contributions of the ECM to vascul
44 This
seminar discusses the important topics of the pathophysi
45 Seminar discussion focused on defining blood deserts and
46 This
Seminar draws attention to advances in the epidemiology,
47 somnia (CBT-I), tai chi chih (TCC), or sleep
seminar education active control condition for 2-hour se
48 As compared with sleep
seminar education active control condition, CBT-I reduce
49 ociety have led a series of joint panels and
seminars focused on the present impact and future direct
50 Although the
Seminar focuses on ARDS due to any cause, we also consid
51 This
Seminar focuses on changes in their epidemiology, the cu
52 This
Seminar focuses on recent advances in our understanding
53 This
Seminar focuses on the diagnosis and management of acute
54 This
Seminar focuses on the diagnosis, complications, and man
55 This
Seminar focuses on the subset of diseases called retinit
56 This
seminar focuses on these changing views and offers a new
57 This
seminar focuses on three common presentations of vertigo
58 are staff in the intervention homes attended
seminars from the hospital outreach team and received we
59 In this
Seminar I present data on the management of children wit
60 The lead author attended a research
seminar in 2017 on WE colonoscopy.
61 itical area and airway clearance techniques'
seminar in person or remotely.
62 The 2016 Beaune
Seminar in Transplant research brought together research
63 ogy and antibody generation, the 2015 Beaune
Seminar in Transplant Research challenged the convention
64 The 2014 Beaune
Seminar in Transplant Research discussed the evidence fo
65 Congress and the 12th International Tinnitus
Seminar in Warsaw, Poland, provided an opportunity to re
66 9 abruptly halted scientific conferences and
seminars in mid-March, forcing the scientific community
67 n , as well as in has been covered in recent
Seminars in The Lancet.
68 ies, didactics in seven, group work in four,
seminars in three, self-directed learning in three and s
69 The
seminar included 5 topics discussed over a 4-d period.
70 This
seminar includes issues of definition and frequency of e
71 pletion of a specific communication training
seminar increased odds of consent by 1.533 (95% CI, 1.25
72 This
Seminar is intended to provide physicians with knowledge
73 ased American Academy of Neurology-sponsored
seminar led by local opinion leaders, and follow-up mail
74 This
Seminar looks at the changing epidemiology of this aller
75 ppreciated by participants, a two-day online
seminar may not be the most appropriate format to genera
76 This
Seminar offers a clinically focused review of the recent
77 This
Seminar offers an updated view on community-acquired pne
78 Specifically, this
Seminar offers practical guidance tailored for primary c
79 011, researchers met for the second Batsheva
Seminar on Integrative Perspectives on the Development o
80 In the decade since the last Lancet
Seminar on lung cancer there have been advances in many
81 We focus this
seminar on these changing views, and offer a new perspec
82 rld is that you can sleep through somebody's
seminar or conference talk and still make the speaker sw
83 This
Seminar outlines the current understanding of head and n
84 "Radiology" are detailed; through workshops,
seminars,
practices, interactive computer game; and desc
85 This
Seminar presents evidence and knowledge that represent t
86 This
Seminar presents the current best practice for the diagn
87 This
Seminar presents the most recent information about the c
88 This
Seminar provides a clinically relevant overview of poten
89 This
Seminar provides a clinically relevant overview of the p
90 This
Seminar provides a concise review and practical guide to
91 This
Seminar provides an overview and update on management of
92 This
Seminar provides an overview of advances in the screenin
93 This
seminar provides an overview of advances in the screenin
94 This JACC Focus
Seminar provides an overview of and highlights recently
95 This
Seminar provides an overview of the current diagnostic a
96 This
Seminar provides an overview of the pathobiology, classi
97 This
Seminar provides an update on epidemiology, pathogenesis
98 This
Seminar provides an update on epidemiology, pathogenesis
99 This
Seminar provides an update on the current knowledge and
100 The scope of this
Seminar ranges from current challenges in pathology, suc
101 itical area and airway clearance techniques'
seminar remotely achieved lower scores than their in-per
102 The educational
seminar resulted in a small, but measurable, increase in
103 This
Seminar reviews COPD with an emphasis on recent advances
104 This
seminar reviews important features and management issues
105 This
seminar reviews the aetiology, clinical presentation, ap
106 This
Seminar reviews the changing epidemiology of invasive my
107 This
seminar reviews the effects of genes, stage of developme
108 This
Seminar reviews the epidemiology, genetics, pathophysiol
109 This final part of a 4-part JACC Focus
Seminar reviews the evidence on the role of the ECM in r
110 This
Seminar reviews the multiple clinical dimensions of syst
111 In this final of a 5-part Focus
Seminar series on precision medicine, we focus on catech
112 Part 3 of a 5-part precision medicine Focus
Seminar series reviews the current status and future opp
113 As explored throughout this JACC Focus
Seminar series, participation in regular exercise offers
114 Here in part 4 of a 4-part
seminar series, the controversies and ambiguities regard
115 In the initial 3 papers in this Focus
Seminar series, the fundamentals and key concepts of pre
116 In this second of a 5-part Focus
Seminar series, we focus on precision medicine in the co
117 Here in this part 3 of a 4-part
seminar series, we focus on these concepts and recent da
118 In this part 1 of a 4-part focus
seminar series, we highlight the mechanisms and physiolo
119 This
Seminar summarises current knowledge of peripartum cardi
120 This
Seminar summarises the presentation, pathophysiology, di
121 y control ranges, and educates users through
seminars,
symposia, and webinars.
122 This
Seminar synthesises the latest insights on HFpEF, integr
123 In January 1999, a virtual
seminar that focused on nutrition education in medical s
124 In this
Seminar,
three types of infection will be covered: tinea
125 The
seminar,
titled "Making Room for Nutrition Education, wa
126 esearch are rapidly evolving, we aim in this
Seminar to provide an up-to-date discussion on select to
127 We created a two-day, online educational
seminar to provide SSc patients with disease-specific in
128 group also took the test 3 months before the
seminar to rule out nonspecific learning.
129 dit reports direct educational workshops and
seminars to address these issues.
130 chures setting expectations, and educational
seminars to residents, advanced practice providers, resi
131 In this
Seminar,
together with diagnosis, management, and treatm
132 s using MAP resources for patients in a case
seminar under supervision (seminar 2).
133 As part of MeDALL, a scientific
seminar was held on January 24, 2011, to review current
134 In this
Seminar we critically appraise the management of Hodgkin
135 In this
Seminar we discuss advances in the understanding of the
136 In this
Seminar we discuss developments from the past 5 years in
137 In this
Seminar we discuss disease burden, recommendations for a
138 In this
Seminar we discuss important advances in the understandi
139 In this
Seminar we discuss the clinical range, diagnostic criter
140 In this
Seminar we discuss the epidemiology, pathophysiology, di
141 In this
Seminar we discuss the epidemiology, pathophysiology, di
142 ve between them, so for the purposes of this
Seminar we have adopted a transdiagnostic perspective.
143 In this
Seminar we present an update of the causes, diagnosis, m
144 In this
Seminar we reflect on changes in its classification crit
145 In this
Seminar we review the causes, anatomy, pathophysiology,
146 In this
Seminar we review the clinical features, diagnosis, and
147 In this
Seminar we will discuss the most common and deadly form
148 Throughout this
Seminar,
we address research needs such as staging of pa
149 In this
Seminar,
we aim to update several important aspects of d
150 In this
Seminar,
we concentrate on clinical manifestations, mole
151 In this
Seminar,
we describe current insights into genetics and
152 In this
Seminar,
we describe recent developments in the diagnosi
153 In this
Seminar,
we discuss clinical and diagnostic approaches a
154 In this
Seminar,
we discuss clinical practice, controversies, an
155 In this
Seminar,
we discuss existing treatment for patients with
156 In this
Seminar,
we discuss pulmonary embolism and deep vein thr
157 In this
Seminar,
we discuss the cause, prognostic models, and ma
158 In this
Seminar,
we discuss the clinical features, diagnosis, an
159 In this
Seminar,
we discuss the clinical presentation, epidemiol
160 In this
Seminar,
we discuss the clinical presentation, transmiss
161 In this
Seminar,
we discuss the definition, epidemiology, differ
162 In this
Seminar,
we discuss the disease burden, pathophysiology,
163 In this
Seminar,
we discuss the epidemiology, causes, and sympto
164 In this
Seminar,
we discuss the main developments in Alzheimer's
165 In this
Seminar,
we discuss updates of key influenza issues for
166 In this
Seminar,
we examine the epidemiology of CKD worldwide, w
167 In this part 1 of a 4-part JACC Focus
Seminar,
we focus on the role, function, and basic biolo
168 In this
Seminar,
we highlight the main developments in the field
169 In this
Seminar,
we outline the classification criteria for SLE,
170 In this
Seminar,
we present an update on the causes, diagnosis,
171 In this
Seminar,
we provide a clinically focused overview of ast
172 In this
Seminar,
we provide a clinically focused overview of ast
173 In this
Seminar,
we provide a comprehensive review that integrat
174 In this
Seminar,
we provide a physician-oriented overview of Cro
175 In this
Seminar,
we provide advice to clinicians on ways to mini
176 In this
Seminar,
we provide an overview of advances in the under
177 In this
Seminar,
we provide an overview of recent evidence regar
178 In this
Seminar,
we provide an overview of the main aspects of r
179 In this
Seminar,
we provide present results regarding rubella co
180 In this
Seminar,
we review its natural history, clinical feature
181 In this
Seminar,
we review our understanding of the risk factors
182 In this
Seminar,
we review recent data on the clinical course, t
183 In this
Seminar,
we review the epidemiology, genetic determinant
184 In this part 3 of a 4-part JACC Focus
Seminar,
we review the evidence on the complex mechanism
185 In this
Seminar,
we review the pathology, diagnostic strategies,
186 In this
Seminar,
we summarise current knowledge regarding ARDS e
187 In this
Seminar,
we summarise the presentation, pathophysiology,
188 se as a so-called red thread throughout this
Seminar,
we will show how personalised management of Par
189 ve meetings, support groups, and educational
seminars were converted to teleconferencing platforms.
190 This
Seminar,
which is aimed at clinicians who manage childre
191 The aim of this
Seminar,
which is intended mainly for primary care physi
192 onsored a 1-day comprehensive breast imaging
seminar,
which was attended by 2,249 radiology residents
193 fore, directly after, and 3 months after the
seminar,
while the waiting list control group also took
194 This
Seminar will compare the epidemiological and clinical fe
195 This
Seminar will focus on the current multidimensional diagn
196 This
Seminar will outline these insights and discuss the stat
197 This
Seminar will review the current understanding of the epi
198 This
Seminar will review the field of type 1 diabetes, highli
199 This focus
seminar will take the reader through the history and piv
200 rs become part of a learning culture through
seminars,
workshops, and clubs in which knowledge and pr
201 ucation and networking opportunities through
seminars,
workshops, and coding sessions while evolving